3D Tissue Models

This person is not registered. Is this you?


Profile Details
Xiu-Ping Wang
Affiliations:

Harvard University

 
Boston, MA USA
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@amyxwang
 
Age:
Bio:
 
Specialty:
Cancer Immunotherapy
 
Presented at Events Covering:
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 42212 / 3501 (What's this?)
Accomplish Score: Unavailable
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 1219
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 0 (0 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 3 (18 / 0)
  • Long-term uninterrupted therapy is essential for maximizing clinical benefits of antiangiogenic drugs (AADs) in cancer patients. ()
  • Published data regarding the overall risks and incidence of hypertension and proteinuria associated with bevacizumab were still unclear. ()
  • Objectives: To develop reliable nomograms to estimate individualized overall survival (OS) and cancer specific survival (CSS) for patients with primary small cell carcinoma of the bladder (SCCB) and compare the predictive value with the AJCC stages. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.